Pharma & Healthcare News Alsiano No. 14 • July 2011
Contents New micro-encapsulated solubiliser for direct compression . ..........................1 Meeting the challenge of age and cellular oxidation ................................3 EXTRAMEL reduces stress and improves vitality .............4 High purity inorganic salts for pharma & biotech from Jost Chemical . ...............5 New study proves rooibos’ antioxidant potency . .............6 Amla - a new addition to the superfruit range ..........7 The Alsiano Healthcare team ........................................8
New micro-encapsulated solubiliser for direct compression SEPITRAPTM is a patented innovation designed for solid oral dosage forms. This micro-encapsulated solubilising agent improves the bioavailability of pharmaceutical active ingredients By Seppic Oral route is the easiest way to administer a drug. In order to cross the intestinal wall to be absorbed, the drug must dissolve into the organism fluids. That is why the solubility and dissolution of drugs are of extreme importance. On the other hand, a molecule must often possess a lipophilic group to have affinity towards the cellular target receptor and, as a consequence, most of the new chemical compounds discovered by high throughput screening have poor water solubility. More than 40% of new chemicals are rejected because of that fact, and still more than 70% of drugs of synthetic nature have solubility issues.
Publisher: Alsiano A/S Circulation: 650 copies Editor-in-chief: Anders Hager Coordinator, text, lay-out: Dorthe Andersson Pharma & Healthcare News is published twice a year and distributed to customers and other interested parties. Reproduction of articles appearing in Pharma & Healthcare News requires prior consent of the author. Alsiano is not responsible for the content of articles written by external authors.
1
Improving bioavailability The most widely used solution for improving bioavailability of a molecule is the use of surfactants. Surfactants are amphiphilic molecules that are able to form micelles with a lipophilic core and a hydrophilic shell creating a tank for the poorly soluble molecules, enabling their absorption. However, the solubilisers are commonly present as liquids compelling the formulator to use the long and energy-costly wet granulation process making tablets or hard capsules. To solve this problem encountered by every pharmaceutical company SEPPIC has an innovative solution: SEPITRAPTM. continues on page 2 >>